
500 experts at the 7th AMR Conference in Basel
That antimicrobial resistance can no longer be considered a silent pandemic became abundantly clear at the AMR Conference in Basel from March 16-17....

Money for AI-powered drug discovery
Antiverse Ltd has reported the discovery of functional antibody clusters targeting two G-protein-coupled receptors (GPCRs), both of which are...

Collaboration to fight cancer
Cancer Research UK and UCB SA have announced to advance two cancer antibodies of the Brussels-based biopharma company to the clinical testing stage....

mbiomics GmbH cashes in €13m in Series A financing
High-Tech Gründerfonds (HTGF) and the state bank Bayern Kapital joined the funding round together with private seed investors.The start-up company...

Novo Holdings invests into standardisation of LC-MS-based proteomics
Novo Holdings, the investment arm of Nordisk A/S has invested €40m in the eight-years-old clinical proteomics specialist Ecosep Aps to benefit from...

Lonza collaborates with Asher Biotherapeutics Inc
Asher Biotherapeutics is a developer of targeted immunotherapies for cancer, chronic viral infections and autoimmune disorders. AB248, Asher Bio’s...

Free sugar linked to higher cardiovascular disease
The findings of a group headed by Rebecca Kelly at University Oxford (doi: 10.1186/s12916-022-02712-7) strengthen the evidence for the global...